Koyfin Home > Directory > Health Care > Antares Pharma > EV / Sales (ntm)

Antares Pharma EV / Sales (ntm) Chart (ATRS)

Antares Pharma annual/quarterly EV / Sales (ntm) from 2002 to 2018.
  • Antares Pharma EV / Sales (ntm) for the quarter ending March 03, 2018 was 5.03 a -61.18% decrease of -3.08 year over year
  • Antares Pharma Annual EV / Sales (ntm) for 2017 was 4.51 a -44.57% decrease of -2.01 from 2016
  • Antares Pharma Annual EV / Sales (ntm) for 2016 was 6.51 a 63.84% increase of 4.16 from 2015
  • Antares Pharma Annual EV / Sales (ntm) for 2015 was 2.36 a -137.28% decrease of -3.23 from 2014
Other Valuation Metrics:
  • Antares Pharma Market Cap for the quarter ending March 03, 2018 was $345m a -45.56% decrease of -157m year over year
  • Antares Pharma Price / Book for the quarter ending March 03, 2018 was 10.27 a -17.66% decrease of -1.81 year over year
  • Antares Pharma Enterprise Value for the quarter ending March 03, 2018 was $338m a -41.44% decrease of -140m year over year
View Chart On Koyfin

Quarterly ATRS EV / Sales (ntm) Data

03/20185.03
12/20174.51
09/20176.81
06/20178.11
03/20177.06
12/20166.51
09/20164.45
06/20162.38
03/20161.85
12/20152.36

Annual ATRS EV / Sales (ntm) Data

20174.51
20166.51
20152.36
20145.59
201314.23
201216.51
20116.63
20104.18
20097.19
20081.27